The Milan System for Reporting Salivary Gland Cytopathology (MSRSGC) developed and published in 2018 recommends grading salivary gland neoplasms into high-grade (HG) or low-grade (LG), given its impact on clinical management.
Although this cytologic grading can be done, in certain cases it can be challenging.
Herein we assess the accuracy of cytologic grading of salivary gland neoplasms at our institution.
